ACUMEN PHARMACEUTICALS INC Share Price Today: Live Updates & Key Insights

ACUMEN PHARMACEUTICALS INC share price today is $2.4369, up 7.02%. The stock opened at $2.32 against the previous close of $2.28, with an intraday high of $2.435 and low of $2.32.

ACUMEN PHARMACEUTICALS INC Share Price Chart

ACUMEN PHARMACEUTICALS INC

us-stock
To Invest in {{usstockname}}
us-stock

ACUMEN PHARMACEUTICALS INC Share Price Performance

$2.4369 0.0702(7.02%) ABOS at 10 Aug 2026 05:43 PM Biotechnology
Lowest Today 2.32
Highest Today 2.435
Today’s Open 2.32
Prev. Close 2.28
52 Week High 3.60
52 Week Low 1.19
Day’s Range: Low 2.32 High 2.435
52-Week Range: Low 1.19 High 3.60
1 day return -
1 Week return +12.21
1 month return -10.14
3 month return -5.62
6 month return -1.81
1 year return +73.3
3 year return -63.92
5 year return -83.69
10 year return -

ACUMEN PHARMACEUTICALS INC Institutional Holdings

RA Capital Management, LLC 29.06

Sands Capital Ventures, LLC 5.15

Alyeska Investment Group, L.P. 3.40

Franklin Resources Inc 3.19

ADAR1 Capital Management LLC 2.99

Knollwood Investment Advisory LLC 2.25

Vanguard Capital Management, LLC 2.09

Franklin Biotechnology Discv A(acc)USD 2.05

FMR Inc 1.60

Vanguard Morn Total Stk Mkt Idx Investor 1.55

Ikarian Capital, LLC 1.46

iShares Russell 2000 ETF 1.44

Hudson Bay Capital Management LP 1.34

Pathstone Holdings LLC 1.19

Franklin Biotechnology Discovery A 1.14

SG Americas Securities, LLC 1.00

Millennium Management LLC 0.91

Susquehanna International Group, LLP 0.83

Two Sigma Investments LLC 0.73

LAURION CAPITAL MANAGEMENT LP 0.73

Vanguard Institutional Extnd Mkt Idx Tr 0.71

Renaissance Technologies Corp 0.66

iShares Russell 2000 Value ETF 0.59

Geode Capital Management, LLC 0.58

Bank of America Corp 0.44

Russell 2000 Equity Index Fund B 0.41

Russell 2000 Index Non-Lendable Fund 0.41

Vanguard Russell 2000 ETF 0.38

BOOTHBAY FUND MANAGEMENT, LLC 0.38

Fidelity Extended Market Index 0.25

State St Russell Sm Cap® Idx SL Cl I 0.24

BSF Systematic US Eq Abs Ret A2 USD 0.23

iShares Micro-Cap ETF 0.22

Schwab Small Cap Index 0.16

A4Investments SICAV SIF ACCI IlanaA2EURH 0.15

NT R2000 Index Fund - NL 0.15

Dimensional US Small Cap ETF 0.14

Vifag 2002 SICAV 0.14

NT R2000 Index Fund - DC - NL - 3 0.13

EA Bridgeway Ultra-Small Company Mkt ETF 0.12

ACUMEN PHARMACEUTICALS INC Market Status

Strong Buy: 5

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

ACUMEN PHARMACEUTICALS INC Fundamentals

Market Cap 164.68 M

PB Ratio 1.7835

PE Ratio 0.0

Enterprise Value 58.77 M

Total Assets 122.83 M

Volume 256799

ACUMEN PHARMACEUTICALS INC Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:1436000 1.4M, FY19:1697000 1.7M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:1436000 1.4M, FY19:1697000 1.7M

Annual Net worth FY23:-48740000 -48.7M, FY22:-40475000 -40.5M, FY21:-181679000 -181.7M, FY20:-7324000 -7.3M, FY19:-7862000 -7.9M

Quarterly Revenue Q1/2026:0 0.0M, Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M

Quarterly Profit Q1/2026:-46000 -0.0M, Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:-45000 -0.0M, Q3/2024:null 0.0M

Quarterly Net worth Q1/2026:-20737000 -20.7M, Q3/2025:-26451000 -26.5M, Q2/2025:-40950000 -41.0M, Q1/2025:-28796000 -28.8M, Q3/2024:-29765000 -29.8M

About ACUMEN PHARMACEUTICALS INC & investment objective

Company Information Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. It focuses on advancing a targeted immunotherapy drug candidate, sabirnetug (ACU193), which is in its Phase 2 ALTITUDE-AD clinical trial to target toxic soluble amyloid beta oligomers. Acumen Pharmaceuticals, Inc. has a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of Sabirnetug, as well as with JCR Pharmaceuticals Co. Ltd for the development of Aß oligomer-targeted enhanced brain delivery therapy for the treatment of Alzheimer's disease. The company was incorporated in 1996 and is headquartered in Newton, Massachusetts.

Organisation Biotechnology

Employees 60

Industry Biotechnology

CEO Mr. Daniel J. O'Connell M.B.A.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

ACUMEN PHARMACEUTICALS INC FAQs

What is the share price of ACUMEN PHARMACEUTICALS INC today?

The current share price of ACUMEN PHARMACEUTICALS INC is $2.4369.

Can I buy ACUMEN PHARMACEUTICALS INC shares in India?

Yes, Indian investors can buy ACUMEN PHARMACEUTICALS INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy ACUMEN PHARMACEUTICALS INC shares in India?

You can easily invest in ACUMEN PHARMACEUTICALS INC shares from India by:

Can I buy fractional shares of ACUMEN PHARMACEUTICALS INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of ACUMEN PHARMACEUTICALS INC?

ACUMEN PHARMACEUTICALS INC has a market cap of $164.68 M.

In which sector does ACUMEN PHARMACEUTICALS INC belong?

ACUMEN PHARMACEUTICALS INC operates in the Biotechnology sector.

What documents are required to invest in ACUMEN PHARMACEUTICALS INC stocks?

To invest, you typically need:

What is the PE and PB ratio of ACUMEN PHARMACEUTICALS INC?

The PE ratio of ACUMEN PHARMACEUTICALS INC is N/A and the PB ratio is 1.78.